Cas 957061-69-7,N-[5-(5-benzenesulphonamido-6-chloropyridin-3-yl)-4-morpholinomethylthiazol-2-yl]acetamide

957061-69-7

Post Buying Request

Basic information

Product Name: N-[5-(5-benzenesulphonamido-6-chloropyridin-3-yl)-4-morpholinomethylthiazol-2-yl]acetamide
Synonyms: N-[5-(5-benzenesulphonamido-6-chloropyridin-3-yl)-4-morpholinomethylthiazol-2-yl]acetamide
CAS NO:957061-69-7
Molecular Formula:
Molecular Weight: 508.022
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-[5-(5-benzenesulphonamido-6-chloropyridin-3-yl)-4-morpholinomethylthiazol-2-yl]acetamide(CAS DataBase Reference)
NIST Chemistry Reference: N-[5-(5-benzenesulphonamido-6-chloropyridin-3-yl)-4-morpholinomethylthiazol-2-yl]acetamide(957061-69-7)
EPA Substance Registry System: N-[5-(5-benzenesulphonamido-6-chloropyridin-3-yl)-4-morpholinomethylthiazol-2-yl]acetamide(957061-69-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 957061-69-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

957061-69-7 Suppliers

Recommended suppliers

957061-69-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 957061-69-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,0,6 and 1 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 957061-69:
(8*9)+(7*5)+(6*7)+(5*0)+(4*6)+(3*1)+(2*6)+(1*9)=197
197 % 10 = 7
So 957061-69-7 is a valid CAS Registry Number.

957061-69-7Upstream product

957061-69-7Downstream Products

957061-69-7Relevant academic research and scientific papers

THIAZOLE DERIVATIVES AND THEIR USE AS ANTI-TUMOUR AGENTS

-

, (2008/06/13)

The invention concerns thiazole derivatives of Formula (I) or pharmaceutically-acceptable salts thereof, wherein each of R, Ring A, m, R1, R2 and R3 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in therapy, for example in the treatment of disease mediated by a PI3K enzyme and/or a mTOR kinase.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 957061-69-7